Filtros : "IQ005" "Tang, Yong" Removido: "2017" Limpar

Filtros



Refine with date range


  • Source: Frontiers Pharmacology. Unidade: IQ

    Subjects: SISTEMA NERVOSO CENTRAL, DOENÇAS DO SISTEMA NERVOSO

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TANG, Yong et al. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.3389/fphar.2023.1355286. Acesso em: 31 out. 2024. , 2024
    • APA

      Tang, Y., Rubini, P., Sperlagh, B., & Ulrich, H. (2024). Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial]. Frontiers Pharmacology. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fphar.2023.1355286
    • NLM

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
    • Vancouver

      Tang Y, Rubini P, Sperlagh B, Ulrich H. Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses [Editorial] [Internet]. Frontiers Pharmacology. 2024 ; 14 1-2 art. 1355286.[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.3389/fphar.2023.1355286
  • Source: Purinergic Signalling. Unidades: ICB, IQ

    Subjects: NEUROTRANSMISSORES, RECEPTORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JUVENAL, Guilherme Araújo et al. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s11302-024-10034-x. Acesso em: 31 out. 2024.
    • APA

      Juvenal, G. A., Higa, G. S. V., Marques, L. B., Zampieri, T. T., Viana, F. J. C., Britto, L. R. G. de, et al. (2024). Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease. Purinergic Signalling. doi:10.1007/s11302-024-10034-x
    • NLM

      Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, Pasquale R de. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2024 ;[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
    • Vancouver

      Juvenal GA, Higa GSV, Marques LB, Zampieri TT, Viana FJC, Britto LRG de, Tang Y, Illes P, Virgilio FD, Ulrich H, Pasquale R de. Regulation of GABAergic neurotransmission by purinergic receptors in brain physiology and disease [Internet]. Purinergic Signalling. 2024 ;[citado 2024 out. 31 ] Available from: https://dx.doi.org/10.1007/s11302-024-10034-x
  • Source: Neurobiology of Disease. Unidade: IQ

    Subjects: TRANSTORNOS MENTAIS, DOENÇAS NEURODEGENERATIVAS, RECEPTORES

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter et al. Purinergic receptors in cognitive disturbances. Neurobiology of Disease, v. 185, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.nbd.2023.106229. Acesso em: 31 out. 2024.
    • APA

      Illes, P., Ulrich, H., Chen, J. F., & Tang, Y. (2023). Purinergic receptors in cognitive disturbances. Neurobiology of Disease, 185, 1-16. doi:10.1016/j.nbd.2023.106229
    • NLM

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
    • Vancouver

      Illes P, Ulrich H, Chen JF, Tang Y. Purinergic receptors in cognitive disturbances [Internet]. Neurobiology of Disease. 2023 ; 185 1-16.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.nbd.2023.106229
  • Source: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Unidade: IQ

    Subjects: NEURÔNIOS, SISTEMA NERVOSO CENTRAL

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAETANO, Roberta Andrejew et al. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Tradução . Cham: Springer, 2023. . . Acesso em: 31 out. 2024.
    • APA

      Caetano, R. A., Turrini, N., Ye, Q., Tang, Y., Illes, P., & Ulrich, H. (2023). Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer.
    • NLM

      Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 out. 31 ]
    • Vancouver

      Caetano RA, Turrini N, Ye Q, Tang Y, Illes P, Ulrich H. Purinergic signaling in neurogenesisand neural fate determination: current knowledge and future challenges. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 out. 31 ]
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: HIDRÓLISE, ESPECTROSCOPIA INFRAVERMELHA

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      YE, Qing et al. Decoupling SERT-nNOS interaction to generate fast-onset antidepressants. Neuroscience Bulletin, v. 39, n. 8, p. 1327-1329, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12264-023-01049-2. Acesso em: 31 out. 2024.
    • APA

      Ye, Q., Lin, S. ‑S., Ulrich, H., & Tang, Y. (2023). Decoupling SERT-nNOS interaction to generate fast-onset antidepressants. Neuroscience Bulletin, 39( 8), 1327-1329. doi:10.1007/s12264-023-01049-2
    • NLM

      Ye Q, Lin S‑S, Ulrich H, Tang Y. Decoupling SERT-nNOS interaction to generate fast-onset antidepressants [Internet]. Neuroscience Bulletin. 2023 ; 39( 8): 1327-1329.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12264-023-01049-2
    • Vancouver

      Ye Q, Lin S‑S, Ulrich H, Tang Y. Decoupling SERT-nNOS interaction to generate fast-onset antidepressants [Internet]. Neuroscience Bulletin. 2023 ; 39( 8): 1327-1329.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12264-023-01049-2
  • Source: Drug Resistance Updates. Unidade: IQ

    Subjects: NEOPLASIAS, PURINAS, PROLIFERAÇÃO CELULAR

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JIA, Wenhui et al. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, v. 70, p. 1-13 art. 100988, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.drup.2023.100988. Acesso em: 31 out. 2024.
    • APA

      Jia, W., Huang, Z., Zhou, L., Liou, Y. -C., Virgilio, F. D., Ulrich, H., et al. (2023). Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, 70, 1-13 art. 100988. doi:10.1016/j.drup.2023.100988
    • NLM

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
    • Vancouver

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
  • Source: Neuropharmacology. Unidade: IQ

    Subjects: NEUROPSIQUIATRIA, DOENÇA DE ALZHEIMER, DEPRESSÃO, TRANSTORNOS DO SONO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RIBEIRO, Deidiane Elisa et al. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease. Neuropharmacology, v. 226, p. 1-16 art. 109371, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2022.109371. Acesso em: 31 out. 2024.
    • APA

      Ribeiro, D. E., Petiz, L. L., Glaser, T., Giacomelli, Á. O., Andrejew, R., Saab, F. de A. R., et al. (2023). Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease. Neuropharmacology, 226, 1-16 art. 109371. doi:10.1016/j.neuropharm.2022.109371
    • NLM

      Ribeiro DE, Petiz LL, Glaser T, Giacomelli ÁO, Andrejew R, Saab F de AR, Milanis M da S, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease [Internet]. Neuropharmacology. 2023 ; 226 1-16 art. 109371.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.neuropharm.2022.109371
    • Vancouver

      Ribeiro DE, Petiz LL, Glaser T, Giacomelli ÁO, Andrejew R, Saab F de AR, Milanis M da S, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease [Internet]. Neuropharmacology. 2023 ; 226 1-16 art. 109371.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.neuropharm.2022.109371
  • Source: Exploration of Neuroprotective Therapy. Unidade: IQ

    Subjects: MITOCÔNDRIAS, AMINOÁCIDOS EXCITATÓRIOS, GLUTAMATOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GLASER, Talita et al. Various facets of excitotoxicity. Exploration of Neuroprotective Therapy, v. 2, p. 36–64, 2022Tradução . . Disponível em: https://doi.org/10.37349/ent.2022.00017. Acesso em: 31 out. 2024.
    • APA

      Glaser, T., Silva, J. B., Juvenal, G. A., Maiolini, P. N., Turrini, N., Petiz, L. L., et al. (2022). Various facets of excitotoxicity. Exploration of Neuroprotective Therapy, 2, 36–64. doi:10.37349/ent.2022.00017
    • NLM

      Glaser T, Silva JB, Juvenal GA, Maiolini PN, Turrini N, Petiz LL, Marques LB, Ribeiro DE, Ye Q, Tang Y, Ulrich H. Various facets of excitotoxicity [Internet]. Exploration of Neuroprotective Therapy. 2022 ; 2 36–64.[citado 2024 out. 31 ] Available from: https://doi.org/10.37349/ent.2022.00017
    • Vancouver

      Glaser T, Silva JB, Juvenal GA, Maiolini PN, Turrini N, Petiz LL, Marques LB, Ribeiro DE, Ye Q, Tang Y, Ulrich H. Various facets of excitotoxicity [Internet]. Exploration of Neuroprotective Therapy. 2022 ; 2 36–64.[citado 2024 out. 31 ] Available from: https://doi.org/10.37349/ent.2022.00017
  • Source: Stem Cell Reviews and Reports. Unidade: IQ

    Subjects: CÉLULAS-TRONCO, DOENÇA DE ALZHEIMER, HIPOCAMPO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAMPOS, Henrique C et al. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease. Stem Cell Reviews and Reports, v. 18, p. 781–791, 2022Tradução . . Disponível em: https://doi.org/10.1007/s12015-021-10321-9. Acesso em: 31 out. 2024.
    • APA

      Campos, H. C., Ribeiro, D. E., Hashiguchi, D., Hukuda, D. Y., Gimenes, C., Romariz, S. A. A., et al. (2022). Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease. Stem Cell Reviews and Reports, 18, 781–791. doi:10.1007/s12015-021-10321-9
    • NLM

      Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SAA, Ye Q, Tang Y, Ulrich H, Longo BM. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease [Internet]. Stem Cell Reviews and Reports. 2022 ; 18 781–791.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12015-021-10321-9
    • Vancouver

      Campos HC, Ribeiro DE, Hashiguchi D, Hukuda DY, Gimenes C, Romariz SAA, Ye Q, Tang Y, Ulrich H, Longo BM. Distinct effects of the hippocampal transplantation of neural and mesenchymal stem cells in a transgenic model of Alzheimer's disease [Internet]. Stem Cell Reviews and Reports. 2022 ; 18 781–791.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12015-021-10321-9
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: AÇÚCAR, CÉREBRO, RECEPTORES

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAO, Xin et al. A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, v. 37, n. 5 p. 754–756, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12264-021-00692-x. Acesso em: 31 out. 2024.
    • APA

      Cao, X., Yin, H. -Y., Ulrich, H., Semyanov, A., & Tang, Y. (2021). A Neural circuit for gut-induced sugar preference. Neuroscience Bulletin, 37( 5 p. 754–756). doi:10.1007/s12264-021-00692-x
    • NLM

      Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12264-021-00692-x
    • Vancouver

      Cao X, Yin H-Y, Ulrich H, Semyanov A, Tang Y. A Neural circuit for gut-induced sugar preference [Internet]. Neuroscience Bulletin. 2021 ; 37( 5 p. 754–756):[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12264-021-00692-x
  • Source: Signal Transduction and Targeted Therapy. Unidade: IQ

    Subjects: PURINAS, DOENÇAS NEURODEGENERATIVAS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HUANG, Zhao et al. From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, v. 6, p. 1-20 art. 162, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41392-021-00553-z. Acesso em: 31 out. 2024.
    • APA

      Huang, Z., Xie, N., Illes, P., Virgilio, F. D., Ulrich, H., Semyanov, A., et al. (2021). From purines to purinergic signalling: molecular functions and human diseases. Signal Transduction and Targeted Therapy, 6, 1-20 art. 162. doi:10.1038/s41392-021-00553-z
    • NLM

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
    • Vancouver

      Huang Z, Xie N, Illes P, Virgilio FD, Ulrich H, Semyanov A, Verkhratsky A, Sperlagh B, Yu S-G, Huang C, Tang Y. From purines to purinergic signalling: molecular functions and human diseases [Internet]. Signal Transduction and Targeted Therapy. 2021 ; 6 1-20 art. 162.[citado 2024 out. 31 ] Available from: https://doi.org/10.1038/s41392-021-00553-z
  • Source: Purinergic Signalling. Unidade: IQ

    Subjects: RECEPTORES, ADENOSINA TRIFOSFATO, FARMACOLOGIA, BIOQUÍMICA, BIOLOGIA MOLECULAR

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WANG, Tao et al. Optical control of purinergic signaling. Purinergic Signalling, v. 17, p. 385–392, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11302-021-09799-2. Acesso em: 31 out. 2024.
    • APA

      Wang, T., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2021). Optical control of purinergic signaling. Purinergic Signalling, 17, 385–392. doi:10.1007/s11302-021-09799-2
    • NLM

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
    • Vancouver

      Wang T, Ulrich H, Semyanov A, Illes P, Tang Y. Optical control of purinergic signaling [Internet]. Purinergic Signalling. 2021 ; 17 385–392.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s11302-021-09799-2
  • Source: Cells. Unidade: IQ

    Subjects: FAGOCITOSE, MACRÓFAGOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ILLES, Peter Illes Peter et al. Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS. Cells, v. 9, n. 5, p. 1-24 art. 1108, 2020Tradução . . Disponível em: https://doi.org/10.3390/cells9051108. Acesso em: 31 out. 2024.
    • APA

      Illes, P. I. P., Rubini, P., Ulrich, H., Zhao, Y., & Tang, Y. (2020). Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS. Cells, 9( 5), 1-24 art. 1108. doi:10.3390/cells9051108
    • NLM

      Illes PIP, Rubini P, Ulrich H, Zhao Y, Tang Y. Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS [Internet]. Cells. 2020 ; 9( 5): 1-24 art. 1108.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/cells9051108
    • Vancouver

      Illes PIP, Rubini P, Ulrich H, Zhao Y, Tang Y. Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS [Internet]. Cells. 2020 ; 9( 5): 1-24 art. 1108.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/cells9051108
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: ANALGÉSICOS, DOR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      REN, Wen-Jing et al. TASK-3: new target for pain-relief. Neuroscience Bulletin, v. 36, n. 8, p. 951–954, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00516-4. Acesso em: 31 out. 2024.
    • APA

      Ren, W. -J., Ulrich, H., Semyanov, A., Illes, P., & Tang, Y. (2020). TASK-3: new target for pain-relief. Neuroscience Bulletin, 36( 8), 951–954. doi:10.1007/s12264-020-00516-4
    • NLM

      Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
    • Vancouver

      Ren W-J, Ulrich H, Semyanov A, Illes P, Tang Y. TASK-3: new target for pain-relief [Internet]. Neuroscience Bulletin. 2020 ; 36( 8): 951–954.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12264-020-00516-4
  • Source: Neuroscience Bulletin. Unidade: IQ

    Subjects: RECEPTORES, DOENÇA DE PARKINSON, DOENÇAS DOS GÂNGLIOS DE BASE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GLASER, Talita et al. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, v. 36, n. 11, p. 1299–1314, 2020Tradução . . Disponível em: https://doi.org/10.1007/s12264-020-00582-8. Acesso em: 31 out. 2024.
    • APA

      Glaser, T., Andrejew, R., Giacomelli, Á. O., Ribeiro, D. E., Marques, L. B., Ye, Q., et al. (2020). Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease. Neuroscience Bulletin, 36( 11), 1299–1314. doi:10.1007/s12264-020-00582-8
    • NLM

      Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12264-020-00582-8
    • Vancouver

      Glaser T, Andrejew R, Giacomelli ÁO, Ribeiro DE, Marques LB, Ye Q, Ren W-J, Semyanov A, Illes P, Tang Y, Ulrich H. Purinergic receptors in basal ganglia diseases: shared molecular Mechanisms between huntington’s and parkinson’s disease [Internet]. Neuroscience Bulletin. 2020 ; 36( 11): 1299–1314.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12264-020-00582-8

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024